about
CD56 expression in human myeloma cells derived from the neurogenic gene expression: possible role of the SRY-HMG box gene, SOX4Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myelomaEstablishing clonal cell lines with endothelial-like potential from CD9(hi), SSEA-1(-) cells in embryonic stem cell-derived embryoid bodies.Acquired del(9)(p22.3) in a primary plasma cell leukemia.Development of Light-Activated CRISPR Using Guide RNAs with Photocleavable Protectors.Non-invasive imaging provides spatiotemporal information on disease progression and response to therapy in a murine model of multiple myeloma.Immunohistochemical evaluation of CD20 expression in patients with multiple myelomaPlasma cell leukemia: case series from a tertiary center with review of literature.Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL-) amyloidosis is associated with response to high-dose melphalan.A list of candidate cancer biomarkers for targeted proteomics.A case of Mollitias and Fragilitas Ossium - unusual presentation of hairy cell leukaemia followed by the diagnosis of nonsecretory myeloma.Functions and uses of immunohistochemical stains in cutaneous infiltrates of hematopoietic origin: a review for the practicing dermatologist.Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma.Immunotherapies targeting CD38 in Multiple Myeloma.IL-6-induced activation of MYC is responsible for the down-regulation of CD33 expression in CD33+ myeloma cells.A key role of GARP in the immune suppressive tumor microenvironment.Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles.IgM myeloma: case report with immunophenotypic profile.Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.Frequent upregulation of MYC in plasma cell leukemia.Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry.Establishment of CD7+ human myeloma sister cell lines, KMS-21-PE and KMS-21-BM, carrying t(11;14) and t(8;14).Chronic idiopathic myelofibrosis terminating in extramedullary anaplastic plasmacytoma.Expansion of CD8+ T cells that express low levels of the B cell-specific molecule CD20 in patients with multiple myeloma
P2860
Q24293769-54130E6C-B08B-4B4F-BFF1-D2E8F61A9D94Q24678112-58D83980-97AB-454D-814E-9B85E303FE88Q33267318-89D145C5-AF0E-417D-8F05-29A0EB29B418Q33410049-20A11725-738A-4CEF-B55F-C759B0808635Q34538256-483524A5-A170-4EA3-9632-0517D53E4CF5Q34540657-AB122DEE-BA3C-430A-9D75-0225BAF3BEA6Q35054893-52D9C894-157B-498E-88E1-ED6581117035Q35851641-638A63D0-E92C-476A-B928-7352FDE393D4Q36384780-FA0E2281-FB87-47CD-A65F-590CEA717D76Q37277962-E5DCD77A-8C56-4281-B86A-6EEA69295696Q37338372-78985585-E1BD-4F77-A436-39D789ED027EQ37863265-F4B43D25-026B-42F9-AA5C-E975E525F257Q38534837-4B6AAB2B-7630-4E00-B727-35A4B6E8D1BCQ39045031-7EF96C34-A43D-49B4-9BC9-4EDAFD29F327Q39877466-4EB37AE4-A040-4322-9A7B-793D4D12C625Q39985213-766E5D3E-0390-4F91-B576-52456720BED4Q44972706-2D7652F5-B7C6-4593-B7DF-E77CD7A2320CQ45065219-E1A3111F-02A2-4B22-98B7-C8ED96FEC804Q47863880-5D18F682-0F6A-4949-A9BD-7B47E47F7A79Q47934970-BAC84219-3DF7-42B8-9780-402684F4A428Q49641900-A91B336A-5F95-4318-8EB0-E1C78CEDB86DQ52832416-E34E88FA-ACBF-45A4-A1CD-873C95040624Q54628962-5F84D517-ECDF-4CBE-A4F6-15E752405928Q57904989-AB395438-095D-4B6D-8645-43E7DBF7153A
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Cell surface markers in multiple myeloma.
@en
type
label
Cell surface markers in multiple myeloma.
@en
prefLabel
Cell surface markers in multiple myeloma.
@en
P1476
Cell surface markers in multiple myeloma.
@en
P2093
G J Ruiz-Argüelles
J F San Miguel
P304
P356
10.1016/S0025-6196(12)61350-0
P407
P577
1994-07-01T00:00:00Z